Research and Engagement on Substance Use: Harnessing Awareness and Personalized Education (RESHAPE) to Improve Well-being and Self-efficacy
Public ClinicalTrials.gov record NCT06952491. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of the RESHAPE study is to learn about the needs and experiences of adults who report having, or being at risk for, substance use disorder. The study will also evaluate engagement with an app-based program designed to support self-monitoring, goal setting, and well-being. The first part of the study will include adults who also report a health-related social need, such as food insecurity, housing instability, unreliable transportation, difficulty paying utility bills, or concerns about personal safety. The main questions this study aims to answer are: * What app features and educational resources do participants find useful? * How do participants engage with study activities, resources, and opportunities to track their substance use and well-being? * How do participants' reported well-being and substance use change over time? * How do activity measures, such as physical activity, sleep, and heart rate, change over time among participants who connect a wearable activity tracker? * How satisfied are participants with the RESHAPE program, and how willing are they to participate in future research? The study has two parts. In Phase 1, 8 to 10 participants will complete a recorded, 60-minute online interview, and approximately 400 other participants will complete a one-time online survey. Researchers will use this information to refine the app-based program. In Phase 2, participants will use the RESHAPE program for approximately one year. They will complete surveys and check-ins about substance use, cravings, well-being, goals, and social circumstances. Participants may also receive personalized graphs, educational resources, and insights based on study data. Those with a connected wearable activity tracker may share activity, sleep, and heart rate data. With their consent, information previously collected through the Evidation platform may also be linked with their study data.
Study identification
- NCT ID
- NCT06952491
- Recruitment status
- Enrolling by invitation
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 1,910 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 22, 2025 (Actual)
- Primary completion
- Dec 2027 (Estimated)
- Completion
- Apr 2028 (Estimated)
- Last update posted
- Oct 16, 2026
2025 – 2028
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Evidation Health | San Mateo | California | 94402 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06952491, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 16, 2026 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06952491 live on ClinicalTrials.gov.